Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SYK | P43405 | 9/20 | 0.49 |
| ▸ | KARS1 | Q15046 | 10/20 | 0.45 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.39 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2859014 | 0.96 | KARS1 (0.48) | SYKKARS1PDCD1CD274 | |
| Bicarbonate SCHEMBL2863054 | 0.95 | SYK (0.48) | SYKKARS1PDCD1CD274 | |
| Bicarbonate SCHEMBL2863059 | 0.94 | SYK (0.47) | SYKKARS1PDCD1CD274 | |
| SCHEMBL2862008 | 0.87 | SYK (0.50) | SYKKARS1 | |
| SCHEMBL2865835 | 0.86 | KARS1 (0.56) | SYKKARS1 | |
| SCHEMBL13136201 | 0.83 | SYK (0.56) | SYKKARS1 | |
| SCHEMBL13136222 | 0.82 | KDR (0.53) | SYKKARS1 | |
| Potassium Ion SCHEMBL2863056 | 0.82 | SYK (0.45) | SYKKARS1 | |
| SCHEMBL2873197 | 0.82 | SYK (0.45) | SYKKARS1 | |
| SCHEMBL13136477 | 0.81 | SYK (0.47) | SYKKARS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7803801-B2 | Aminopyridine compounds having Syk inhibitory activity | JAPAN TOBACCO, INC. (JP) | 2010-09-28 | — | — | US | disclosed |
| EP-1854793-A1 | NOVEL AMINOPYRIDINE COMPOUND WITH Syk INHIBITORY ACTIVITY | Japan Tobacco, Inc. (JP) | 2007-11-14 | — | — | EP | disclosed |
| US-20060205731-A1 | Novel aminopyridine compounds having Syk inhibitory activity | JAPAN TOBACCO INC. (JP) | 2006-09-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060205731-A1 | Novel aminopyridine compounds having Syk inhibitory activity | SYK, BTK, ZAP70 | SYK 1/4885KARS1 2175/4885PDCD1 1601/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.